A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours
3B Pharmaceuticals GmbH
3B Pharmaceuticals GmbH
Bicara Therapeutics
Leap Therapeutics, Inc.
Revolution Medicines, Inc.
Carisma Therapeutics Inc
University of Oxford
Pfizer
DNAtrix, Inc.
Fate Therapeutics
Karyopharm Therapeutics Inc
Amgen
Revolution Medicines, Inc.
Georgetown University
Novartis
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Stanford University